Oncosil Medical Ltd has released a press release.
OncoSil Medical: Half Yearly Report Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- OncoSil approved for Innovation Funding (NUB) in Germany
- PanCO Clinical Study on OncoSil Published in ESMO Open
- 2021 AGM CEO Presentation
- Receipt of $1.077m R&D Tax Incentive Refund
- OncoSil TGA regulatory update
Later from OncoSil Medical
- Fully-Funded Trial Approved In Germany
- First Commerical Pancreas Treatment In Spain
- OncoSil Signs Commercial Agreement With Hospital In Spain
- OncoSil Launches $10m Capital Raising
- Clarification Of Non-Renouncable Entitlement Offer Details
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical